Terconazole - a new broad-spectrum antifungal

Area of Science:

• Mycology
• Pharmacology
• Medicinal Chemistry

Background:

• Fungal infections, including candidosis and dermatophytosis, pose significant health challenges.
• Development of novel antifungal agents with broad-spectrum activity and favorable safety profiles is crucial.

Purpose of the Study:

• To evaluate the in vitro and in vivo antifungal efficacy of terconazole, a new triazole ketal.
• To assess the spectrum of activity and potential therapeutic applications of terconazole.

Main Methods:

• In vitro susceptibility testing against various yeasts and fungi.
• Assessment of antifungal activity in experimental models of dermatophytosis and candidosis.
• Evaluation of topical and oral administration routes.

Main Results:

• Terconazole exhibited high in vitro activity against a broad range of yeasts and mycelium-forming fungi.
• The agent effectively prevented the morphogenetic transformation of Candida albicans.
• Terconazole demonstrated high in vivo activity in topical treatments for experimental dermatophytosis and candidosis.
• Moderate broad-spectrum oral activity was observed, with no side effects.

Conclusions:

• Terconazole is a potent antifungal agent with broad-spectrum activity.
• It shows promise for topical and oral treatment of fungal infections.
• The absence of side effects suggests a favorable safety profile for terconazole.